The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma—including the analysis of clinicopathological factors influencing relative dose intensity

Recently, it has been reported that the relative dose intensity (RDI) of adjuvant chemotherapy (AC) influences survival in various cancers, but there are very few reports about RDI in pancreatic ductal adenocarcinoma (PDAC). The optimal timing for initiation of AC for PDAC also remains unknown. The...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Yabusaki, Norimitsu, Fujii, Tsutomu, Yamada, Suguru, Murotani, Kenta, Sugimoto, Hiroyuki, Kanda, Mitsuro, Nakayama, Goro, Koike, Masahiko, Fujiwara, Michitaka, Kodera, Yasuhiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2016
Gaiak:
3700
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265784/
https://ncbi.nlm.nih.gov/pubmed/27442667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004282
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak